Women's heart health is at a critical point, and AI is offering
new hope. On the latest Disruption Interruption podcast, host
Karla Jo Helms is joined by
Dino Martis, Co-founder and CEO of
Genexia, a HealthTech leader using AI to revolutionize early
detection of coronary artery disease (CAD) in women. Martis shares
how technology is transforming preventive healthcare.
TAMPA
BAY, Fla., Sept. 17, 2024 /PRNewswire-PRWeb/ -- A
century ago, heart disease was largely misunderstood and considered
a man's disease, with little known about how it affected
women—because nobody thought it did. Recent statistics show that
cardiovascular disease (CVD) affects about one in three women in
the U.S. and is the leading cause of death, responsible for
approximately 500,000 deaths annually. Diagnosis and treatment gaps
persist due to women's differing symptoms and their historical
underrepresentation in clinical research. (1) Karla Jo Helms (KJ), host of the Disruption
Interruption podcast, has an eye-opening conversation with
Dino Martis, Co-founder and CEO of
Genexia. He explains how the company is implementing explainable AI
to address critical health disparities and enhance preventive care.
"Our goal is to democratize health care and improve diagnostic
accuracy for coronary artery disease among women," says Martis. "By
integrating this advanced AI technology into mammograms, we are
providing an invaluable service that enhances early detection and
potentially saves lives."
"Our goal is to democratize health care and
improve diagnostic accuracy for coronary artery disease among
women," says Dino Martis. "By
integrating advanced AI into mammograms, we enhance early detection
and potentially save lives."
Genexia's Innovative Approach to Closing Cardiovascular
Diagnosis Gaps
Women often present symptoms of cardiovascular disease differently
from men, leading to significant gaps in diagnosis and treatment. A
historical lack of female representation in clinical studies
compounds this disparity.
Genexia has developed a novel approach that integrates
cardiovascular risk assessment with routine mammography screenings
to address these challenges. "We are introducing a quantitative
cardiovascular risk diagnosis alongside the preventative breast
cancer screenings that women already undergo," explains Martis.
This approach identifies CAD risk early, offering preventative
rather than reactive treatments.
Cost-Effectiveness and Life-Saving Potential of Preventive
Cardiovascular Care
Martis also notes the financial benefits of preventive care, both
for patients and insurers. "Preventive medicine is much more
cost-effective compared to treating advanced heart conditions," he
stated. "Early intervention can significantly reduce healthcare
costs and improve the quality of life for patients."
This innovative approach is poised to make a substantial impact on
women's health, offering a practical and integrated solution to
cardiovascular risk assessment. As Martis concludes, "Our goal is
to reduce deaths by 50% by catching cardiovascular issues early and
changing the clinical pathway for those at risk."
Links
Disrupting Heart Disease as the Top Killer of Women: Trustworthy AI
with Dino Martis to the Rescue:
https://omny.fm/shows/disruption-interruption/disrupting-heart-disease-as-the-top-killer-of-wome?in_playlist=podcast
LinkedIn: https://www.linkedin.com/in/dino-martis/
X: https://twitter.com/Dino_Martis
Company Website: https://genexia.co/
Disruption Interruption is the podcast where you will hear from
today's biggest Industry Disruptors. Learn what motivated them to
bring about innovation and how they overcame opposition to
adoption.
Disruption Interruption can be listened to in Apple's App Store and Spotify.
About Disruption InterruptionTM
Disruption is happening on an unprecedented scale, impacting all
manner of industries— MedTech, Finance, IT, eCommerce, shipping,
logistics, and more—and COVID has moved their timelines up a full
decade or more. But WHO are these disruptors and when did they say,
"THAT'S IT! I'VE HAD IT!"? Time to Disrupt and Interrupt with host
Karla Jo "KJ" Helms, veteran communications disruptor. KJ
interviews badasses who are disrupting their industries and
altering economic networks that have become antiquated with an
establishment resistant to progress. She delves into uncovering
secrets from industry rebels and quiet revolutionaries that uncover
common traits—and not-so-common—that are changing our economic
markets… and lives. Visit the world's key pioneers that persist to
success, despite arrows in their backs at
http://www.disruption-interruption.com.
About Dino Martis
Dino Martis is the CEO and Founder
of Genexia LLC, a pioneering company dedicated to developing
scalable and innovative solutions in healthcare, insurance, sales,
manufacturing, and aerospace. With 25 years of experience in both
domestic and international business leadership, Dino is a
passionate advocate for AI-driven innovation and business model
re-engineering. Alongside co-founders Kelly
Cohen and Anoop Satyam, Dino
is leading Genexia's mission to harness explainable AI for early
detection of coronary artery disease (CAD) in women, focusing on
improving health outcomes and reducing mortality through advanced,
accessible diagnostics.
About Karla Jo Helms
Karla Jo Helms is the Chief
Evangelist and Anti-PR® Strategist for JOTO PR Disruptors™.
Karla Jo learned firsthand how
unforgiving business can be when millions of dollars are on the
line — and how the control of public opinion often determines
whether one company is happily chosen, or another is brutally
rejected. Being an alumnus of crisis management, Karla Jo has worked with litigation attorneys,
private investigators, and the media to help restore companies of
goodwill into the good graces of public opinion — Karla Jo operates on the ethic of getting it
right the first time, not relying on second chances and doing what
it takes to excel. Helms speaks globally on public relations, how
the PR industry itself has lost its way, and how, in the right
hands, corporations can harness the power of Anti-PR to drive
markets and impact market perception.
References
1. "2023 Heart Disease and Stroke Statistics
Update Fact Sheet." American Heart Association, 2023,
professional.heart.org/-/media/PHD-Files-2/Science-News/2/2023-Heart-and-Stroke-Stat-Update/2023-Statistics-At-A-Glance-final_1_17_23.pdf.
Media Inquiries:
Karla Jo Helms
JOTO PR™
727-777-4629
jotopr.com
Media Contact
Karla Jo Helms, JOTO PR™,
727-777-4629, khelms@jotopr.com, jotopr.com
View original content to download
multimedia:https://www.prweb.com/releases/disrupting-heart-health-genexias-breakthrough-ai-for-early-coronary-diagnosis-in-women-302250610.html
SOURCE JOTO PR™